Development of a novel assay method for colistin sulphomethate

Mandy Wootton; H. A. Holt; A. P. MacGowan

doi:10.1111/j.1469-0691.2005.01076.x

Development of a novel assay method for colistin sulphomethate

Mandy Wootton^*
, H. A. Holt
, A. P. MacGowan

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

22 Citations (Scopus)

Abstract

Increased use of colistin therapy for infections caused by Pseudomonas aeruginosa has indicated a need for a more robust microbiological assay technique. This report describes a quick and simple microbiological assay for quantifying levels of colistin sulphomethate in serum and urine samples from cystic fibrosis patients. The technique uses no specialised or costly equipment and is suitable for use in all routine diagnostic microbiology laboratories.

Original language	English
Pages (from-to)	243-244
Number of pages	2
Journal	Clinical Microbiology and Infection
Volume	11
Issue number	3
DOIs	https://doi.org/10.1111/j.1469-0691.2005.01076.x
Publication status	Published - Mar 2005
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Assay method
Bioassay
Colistin
Cystic fibrosis
Pseudomonas aeruginosa

Access to Document

10.1111/j.1469-0691.2005.01076.x

Cite this

@article{93c5eb3f5b3b4a10b659c376af72a5d4,

title = "Development of a novel assay method for colistin sulphomethate",

abstract = "Increased use of colistin therapy for infections caused by Pseudomonas aeruginosa has indicated a need for a more robust microbiological assay technique. This report describes a quick and simple microbiological assay for quantifying levels of colistin sulphomethate in serum and urine samples from cystic fibrosis patients. The technique uses no specialised or costly equipment and is suitable for use in all routine diagnostic microbiology laboratories.",

keywords = "Assay method, Bioassay, Colistin, Cystic fibrosis, Pseudomonas aeruginosa",

author = "Mandy Wootton and Holt, \{H. A.\} and MacGowan, \{A. P.\}",

year = "2005",

month = mar,

doi = "10.1111/j.1469-0691.2005.01076.x",

language = "English",

volume = "11",

pages = "243--244",

journal = "Clinical Microbiology and Infection",

issn = "1198-743X",

publisher = "Elsevier B.V.",

number = "3",

}

TY - JOUR

T1 - Development of a novel assay method for colistin sulphomethate

AU - Wootton, Mandy

AU - Holt, H. A.

AU - MacGowan, A. P.

PY - 2005/3

Y1 - 2005/3

N2 - Increased use of colistin therapy for infections caused by Pseudomonas aeruginosa has indicated a need for a more robust microbiological assay technique. This report describes a quick and simple microbiological assay for quantifying levels of colistin sulphomethate in serum and urine samples from cystic fibrosis patients. The technique uses no specialised or costly equipment and is suitable for use in all routine diagnostic microbiology laboratories.

AB - Increased use of colistin therapy for infections caused by Pseudomonas aeruginosa has indicated a need for a more robust microbiological assay technique. This report describes a quick and simple microbiological assay for quantifying levels of colistin sulphomethate in serum and urine samples from cystic fibrosis patients. The technique uses no specialised or costly equipment and is suitable for use in all routine diagnostic microbiology laboratories.

KW - Assay method

KW - Bioassay

KW - Colistin

KW - Cystic fibrosis

KW - Pseudomonas aeruginosa

UR - https://www.scopus.com/pages/publications/14844360655

U2 - 10.1111/j.1469-0691.2005.01076.x

DO - 10.1111/j.1469-0691.2005.01076.x

M3 - Article

C2 - 15715726

AN - SCOPUS:14844360655

SN - 1198-743X

VL - 11

SP - 243

EP - 244

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

IS - 3

ER -

Development of a novel assay method for colistin sulphomethate

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this